1. 1. Douglas-Escobar M and Weiss MD (2015) Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr, 169(4): 397-403. [ DOI:10.1001/jamapediatrics.2014.3269] 2. Yang L (2020) Treatment and new progress of neonatal hypoxic-ischemic brain damage. Histol Histopathol, 35(9): 929-36. 3. Al-Macki N (2009) The spectrum of abnormal neurologic outcomes subsequent to term intrapartum asphyxia. Pediatr Neurol, 41(6): 399-405. [ DOI:10.1016/j.pediatrneurol.2009.06.001] 4. Barnett A (2002) Neurological and perceptual-motor outcome at 5-6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI. Neuropediatrics, 33(5): 242-8. [ DOI:10.1055/s-2002-36737] 5. Greco P (2020) Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg, 120(2): 277-88. [ DOI:10.1007/s13760-020-01308-3] 6. Yıldız EP (2017) Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev Neurother, 17(5): 449-59. [ DOI:10.1080/14737175.2017.1259567] 7. Liu F and McCullough LD (2013) Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol Sin, 34(9): 1121-30. [ DOI:10.1038/aps.2013.89] 8. Silveira RC and Procianoy RS (2015) Hypothermia therapy for newborns with hypoxic ischemic encephalopathy. J Pediatr (Rio J), 91(6 Suppl 1): S78-83. [ DOI:10.1016/j.jped.2015.07.004] 9. Ceyzériat K, Zilli T, Millet P, Koutsouvelis N, Dipasquale G, Fossey C, et al. (2022) Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats. J Neuroinflammation, 19(1): 311. [ DOI:10.1186/s12974-022-02673-x] 10. Narasimhamurthy RK, Mumbrekar KD, Satish Rao BS (2022) Effects of low dose ionizing radiation on the brain- a functional, cellular, and molecular perspective. Toxicology, 465: 153030. [ DOI:10.1016/j.tox.2021.153030] 11. Schmal Z, Hammer B, Müller A, Rübe CE (2021) Fractionated Low-Dose Radiation Induces Long-Lasting Inflammatory Responses in the Hippocampal Stem Cell Niche. Int J Radiat Oncol Biol Phys, 111(5): 1262-75. [ DOI:10.1016/j.ijrobp.2021.07.007] 12. Disdier C (2018) Anti-cytokine therapy to attenuate ischemic-reperfusion associated brain injury in the perinatal period. Brain Sci, 8(6): 98. [ DOI:10.3390/brainsci8060101] 13. Nijboer CH (2008) A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke, 39(9): 2578-86. [ DOI:10.1161/STROKEAHA.108.516401] 14. Rocha-Ferreira E (2017) Systemic pro-inflammatory cytokine status following therapeutic hypothermia in a piglet hypoxia-ischemia model. J Neuroinflammation, 14(1): 44. [ DOI:10.1186/s12974-017-0821-x] 15. Boyd A, Byrne S, Middleton RJ, Banati RB, Liu G-J (2021) Control of Neuroinflammation through Radiation-Induced Microglial Changes. Cells, 10(9): 2181. [ DOI:10.3390/cells10092381] 16. Ceyzériat K, Jaques E, Gloria Y, Badina A, Millet P, Koutsouvelis N, et al. (2024) Low-dose radiation therapy impacts microglial inflammatory response without modulating amyloid load in female TgF344-AD rats. J Alzheimer's Disease, 98(3): 1001-16. [ DOI:10.3233/JAD-231153] 17. Wassink G (2014) The mechanisms and treatment of asphyxial encephalopathy. Front Neurosci, 8: 40. [ DOI:10.3389/fnins.2014.00040] 18. Orrock JE (2016) Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy. Pediatr Res, 79(5): 742-7. [ DOI:10.1038/pr.2015.280] 19. Balduini W (2012) The use of melatonin in hypoxic-ischemic brain damage: an experimental study. J Matern Fetal Neonatal Med, 25(1): 119-24. [ DOI:10.3109/14767058.2012.663232] 20. Cardinali DP (2019) An assessment of melatonin's therapeutic value in the hypoxic-ischemic encephalopathy of the newborn. Front Synaptic Neurosci, 11: 34. [ DOI:10.3389/fnsyn.2019.00034] 21. Deng WG (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood, 108(2): 518-24. [ DOI:10.1182/blood-2005-09-3691] 22. Koh PO (2008) Melatonin regulates nitric oxide synthase expression in ischemic brain injury. J Vet Med Sci, 70(7): 747-50. [ DOI:10.1292/jvms.70.747] 23. Martínez-Orgado J (2020) Cannabidiol for the treatment of neonatal hypoxic-ischemic brain injury. Front Pharmacol, 11: 584533. [ DOI:10.3389/fphar.2020.584533] 24. Li B (2017) Brain-immune interactions in perinatal hypoxic-ischemic brain injury. Prog Neurobiol, 159: 50-68. [ DOI:10.1016/j.pneurobio.2017.10.006] 25. Rocha-Ferreira E and Hristova M (2016) Plasticity in the neonatal brain following hypoxic-ischaemic injury. Neural Plast, 2016: 4901014. [ DOI:10.1155/2016/4901014] 26. Tuor UI (1993) Glucocorticoid prevention of neonatal hypoxic-ischemic damage: role of hyperglycemia and antioxidant enzymes. Brain Res, 604(1-2): 165-72. [ DOI:10.1016/0006-8993(93)90364-S] 27. Tuor UI (1997) Dexamethasone prevents hypoxia/ischemia-induced reductions in cerebral glucose utilization and high-energy phosphate metabolites in immature brain. J Neurochem, 69(5): 1954-63. [ DOI:10.1046/j.1471-4159.1997.69051954.x] 28. Carty ML (2011) Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia-ischemia in the immature rodent brain. Brain Res, 1402: 9-19. [ DOI:10.1016/j.brainres.2011.06.001] 29. Wixey JA (2012) Post-insult ibuprofen treatment attenuates damage to the serotonergic system after hypoxia-ischemia in the immature rat brain. J Neuropathol Exp Neurol, 71(12): 1137-46. [ DOI:10.1097/NEN.0b013e318277d4c7] 30. Chiappetta O (2007) Evidence to implicate early modulation of interleukin-1β expression in the neuroprotection afforded by 17β-estradiol in male rats undergone transient middle cerebral artery occlusion. Int Rev Neurobiol, 82: 357-72. [ DOI:10.1016/S0074-7742(07)82019-8] 31. Deutsch ER (2013) Progesterone's role in neuroprotection: a review of the evidence. Brain Res, 1530: 82-105. [ DOI:10.1016/j.brainres.2013.07.014] 32. Durán-Carabali LE (2023) Protective effect of sex steroid hormones on morphological and cellular outcomes after neonatal hypoxia-ischemia: A meta-analysis of preclinical studies. Neurosci Biobehav Rev, 145: 105018. [ DOI:10.1016/j.neubiorev.2022.105018] 33. Li X (2014) Effects of progesterone on hippocampal ultrastructure and expression of inflammatory mediators in neonatal rats with hypoxic-ischemic brain injury. Exp Ther Med, 7(5): 1311-6. [ DOI:10.3892/etm.2014.1589] 34. Mirza MA (2015) Sexually dimorphic outcomes and inflammatory responses in hypoxic-ischemic encephalopathy. J Neuroinflammation, 12: 32. [ DOI:10.1186/s12974-015-0251-6] 35. Perez-Alvarez MJ and Wandosell F (2016) Stroke and neuroinflammation: role of sexual hormones. Curr Pharm Des, 22(10): 1334-49. [ DOI:10.2174/138161282210160304112834] 36. Ji G (2015) NF-κB signaling is involved in the effects of intranasally engrafted human neural stem cells on neurofunctional improvements in neonatal rat hypoxic-ischemic encephalopathy. CNS Neurosci Ther, 21(12): 926-35. [ DOI:10.1111/cns.12441] 37. Au NPB, Wu T, Kumar G, Jin Y, Li YYT, Chan SL, et al. (2024) Low-dose ionizing radiation promotes motor recovery and brain rewiring by resolving inflammatory response after brain injury and stroke. Brain, Behavior, and Immunity, 115: 43-63. [ DOI:10.1016/j.bbi.2023.09.015] 38. Le Reun E and Foray N (2023) Low-dose radiation therapy (LDRT) against cancer and inflammatory or degenerative diseases: Three parallel stories with a common molecular mechanism involving the nucleoshuttling of the ATM protein? Cancers, 15(5): 1482. [ DOI:10.3390/cancers15051482] 39. Voshart DC, Oshima T, Jiang Y, van der Linden GP, Ainslie AP, Reali Nazario L, et al. (2024) Radiotherapy induces persistent innate immune reprogramming of microglia into a primed state. Cell Reports, 43(2): 113764. [ DOI:10.1016/j.celrep.2024.113764] 40. Donaubauer A-J, Becker I, Weissmann T, Fröhlich BM, Muñoz LE, Gryc T, et al. (2021) Low dose radiation therapy induces long-lasting reduction of pain and immune modulations in the peripheral blood - interim analysis of the IMMO-LDRT01 trial. Frontiers in Immunology, 12: 2021. [ DOI:10.3389/fimmu.2021.740742] 41. Schmal Z, Hammer B, Müller A, Rübe CE (2021) Fractionated low-dose radiation induces long-lasting inflammatory responses in the hippocampal stem cell niche. Int J Radiat Oncol Biol Phys, 111(5): 1262-75. [ DOI:10.1016/j.ijrobp.2021.07.007] 42. Papini C, Mirzaei S, Xing M, Tonning Olsson I, Salloum R, de Blank PMK, et al. (2025) Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades. Neuro Oncol, 27(1): 254-66. [ DOI:10.1093/neuonc/noae119] 43. Ceyzériat K, Jaques E, Gloria Y, Badina A, Millet P, Koutsouvelis N, et al. (2024) Low-dose radiation therapy impacts microglial inflammatory response without modulating amyloid load in female TgF344-AD rats. J Alzheimers Dis, 98(3): 1001-16. [ DOI:10.3233/JAD-231153] 44. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet, 380(9840): 499-505. [ DOI:10.1016/S0140-6736(12)60815-0] 45. Cherlow JM, Shaw DWW, Margraf LR, Bowers DC, Huang J, Fouladi M, et al. (2019) Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221. Int J Radiat Oncol Biol Phys, 103(4): 861-8. [ DOI:10.1016/j.ijrobp.2018.11.004] 46. Brody AS, Frush DP, Huda W, Brent RL (2007) Radiation risk to children from computed tomography. Pediatrics, 120(3): 677-82. [ DOI:10.1542/peds.2007-1910] 47. Voshart DC, Oshima T, Jiang Y, van der Linden GP, Ainslie AP, Reali Nazario L, et al. (2024) Radiotherapy induces persistent innate immune reprogramming of microglia into a primed state. Cell Rep, 43(2): 113764. [ DOI:10.1016/j.celrep.2024.113764] 48. Donaubauer AJ, Becker I, Weissmann T, Fröhlich BM, Muñoz LE, Gryc T, et al. (2021) Low dose radiation therapy induces long-lasting reduction of pain and immune modulations in the peripheral blood - interim analysis of the IMMO-LDRT01 trial. Front Immunol, 12: 740742. [ DOI:10.3389/fimmu.2021.740742]
|